On an overcast Tuesday in December, Michael Hale stood before a group of students at the Portland Opportunities Industrial ...

People with high blood pressure who slept for shorter durations were more likely to show poor cognitive function and ...

In March, we reported on back-to-back FDA approvals for two treatments in pulmonary arterial hypertension (PAH). In this ...

RTN-001 is under clinical development by Retension Pharmaceuticals and currently in Phase II for Hypertension.

PAH, or pulmonary hypertension, can leave someone breathless even after a short walk, but better drug combinations have ...

Short sleep duration that persists during pregnancy and for two to seven years after delivery is associated with incre ...

The top articles about pulmonary arterial hypertension (PAH) in 2024 included FDA approvals, the effect of salt substitutes ...

The study highlighted interventions to reduce heart failure risk — most notably hypertension control and weight loss.

The prevalence of idiopathic intracranial hypertension in US women varies geographically, some of which is explained by the varying prevalence of obesity.

Hypertension can lead to serious health issues without presenting noticeable symptoms. Despite this, it remains one of the ...

A collaborative study from physician researchers at the University of Cincinnati College of Medicine is shining new light on ...

Dietary Changes: Reduce sodium intake by avoiding processed foods. Instead, opt for potassium-rich options like bananas, ...